logo
Select company
Select metric
$ -0.62EBITDA per Share
VS
Market
22
Sector
55
Industry
72
History
85
$ 0.86Close
$ 0.79 - $ 3.1 52-Week Range
Ticker Information

Ticker

LEXX

Company Name

LEXARIA BIOSCIENCE CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LEXARIA BIOSCIENCE CORP - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LEXX - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -11.27M$ -0.62118.3M
3/31/2025$ -9.28M$ -0.53117.51M
12/31/2024$ -7.2M$ -0.43116.67M
9/30/2024$ -5.68M$ -0.46112.38M
6/30/2024$ -4.63M$ -0.33113.86M
3/31/2024$ -5.24M$ -0.49110.77M
12/31/2023$ -5.91M$ -0.6519.05M
9/30/2023$ -6.52M$ -0.9916.61M
6/30/2023$ -6.89M$ -1.0716.44M
3/31/2023$ -6.9M$ -1.1615.95M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LEXARIA BIOSCIENCE CORP's latest trailing twelve months (TTM) EBITDAPS stands at $ -1.43.
  • Over the past 5 years, LEXARIA BIOSCIENCE CORP's average EBITDAPS has been $ -0.87.
  • The median EBITDAPS for LEXARIA BIOSCIENCE CORP during this period was $ -0.92
  • LEXARIA BIOSCIENCE CORP reached its highest EBITDAPS over the past 5 years at $ -0.33.
  • The lowest EBITDAPS recorded by LEXARIA BIOSCIENCE CORP in the same timeframe $ -1.43

LEXARIA BIOSCIENCE CORP's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
BRTX : BIORESTORATIVE THERAPIES INC $ -1.19IBIO : IBIO INC $ -1.62ERNA : ERNEXA THERAPEUTICS INC $ -7.31ICU : SEASTAR MEDICAL HOLDING CORP $ -1.29RLYB : RALLYBIO CORP $ -0.93LYRA : LYRA THERAPEUTICS INC $ -28.45PULM : PULMATRIX INC $ -2.17VYNE : VYNE THERAPEUTICS INC $ -0.9APRE : APREA THERAPEUTICS INC $ -2.44MGRX : MANGOCEUTICALS INC $ -1.31

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for LEXARIA BIOSCIENCE CORP is calculated as follows: EBITDA [ $ -3.97M ] / (Shares WA [ 2.77M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -1.43 ]

LEXX - EBITDA per Share, Last 5 years

$ -1.43

Minimum

Sep 30, 2020

$ -0.33

Maximum

Jun 30, 2024

$ -0.87

Average

$ -0.92

Median

EBITDAPS Benchmark Analysis

The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28